{"cdcTestId":"2013-0539","testcaseName":"3 single antigen doses: 2 Measles; 1 Rubella","vaccineGroup":"MMR","evaluationTestType":"Single Antigen Administration","forecastTestType":"Recommended based on minimum interval from live virus vaccine","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2020-11-07T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2021-12-15T00:00:00","vaccineName":"ATTENUVAX","cvx":"05","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-06-01T00:00:00","vaccineName":"MERUVAX II","cvx":"06","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"ATTENUVAX","cvx":"05","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"1","earliestDate":"2022-11-16T00:00:00","recommendedDate":"2022-11-16T00:00:00","pastDueDate":"2022-11-16T00:00:00"},"doses":[{"dateAdministered":"2021-12-15T00:00:00","vaccineName":"ATTENUVAX","cvx":"05","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-06-01T00:00:00","vaccineName":"MERUVAX II","cvx":"06","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"ATTENUVAX","cvx":"05","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2019-08-22T07:27:32.366","generalDescription":"This test case describes when a child is administered single antigen dose of Measles and Rubella, at the minimum age of 12 months, and a second dose of the Measles vaccine  at least 4 weeks later, that a second dose of the Rubella vaccine is recommended.","changedInVersion":"1.1","reasonForChange":"Renamed to better reflect test case."}